Comparative Study of the Postprandial Glycemic Profile After Consumption of a High-fat Meal (Pizza) Between the Open-loop System (Medtronic MiniMed 640G) and the Hybrid Closed-loop System (Medtronic MiniMed 780G) in Patients With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Pumps.
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this interventional clinical study is to compare the postprandial glycemic profile of patients with type 1 diabetes using either an open-loop (Medtronic Minimed 640G) or closed-loop (Medtronic Minimed 780G) insulin pump, after consuming a high-fat meal (pizza). The new advanced Medtronic MiniMed 780G insulin pump (closed hybrid loop) features an advanced algorithm that enables the automatic administration of corrective microdoses of insulin (microboluses) every 5 minutes. The open-loop pump offers the option of a dual-wave bolus pattern for insulin delivery, which is currently considered the best approach for managing such high-fat meals, a feature that is not available in the closed-loop pump. The main questions to answer are:
- 1.To what extent can the new closed-loop insulin pump with automatic corrective microdoses of insulin manage the late postprandial hyperglycemia caused by a high-fat meal like pizza, which is extremely difficult for type 1 diabetes patients to manage?
- 2.To what extent should protein and fat, in addition to carbohydrates, be accounted for in patients with type 1 diabetes using the closed-loop pump when consuming high-fat meals like pizza? Participants will be adults (\> 18years old) with type 1 diabetes using the MiniMed 780G pump (with either aspart or lispro insulin) and who are regularly followed up at the Insulin Pump Outpatient Department of the Diabetes Center of the Laiko General Hospital, National and Kapodistrian University of Athens Medical School, in Athens, Greece. They will undergo three study visits. During these visits, different strategies for managing a high-fat meal will be compared using both the closed-loop and open-loop modes of the insulin pump. A brief clinical history will be taken (duration of diabetes, conditions at initial diagnosis, treatment regimen, complications), and anthropometric measurements (height, weight, waist circumference) will be recorded. Data from the insulin pumps will be uploaded to a computer to document the pump's basic settings (insulin-to-carbohydrate ratio, insulin sensitivity factor, hourly basal rates, glucose target, active insulin time), and the most recent HbA1c value will be noted. The meal test will start only if the sensor glucose level upon arrival is below 180 mg/dL. An intravenous catheter will be placed in a forearm vein for repeated blood sampling to measure venous glucose levels at time 0 (pre-meal), 30, 60, 90, 120, 150, 180, 210, and 240 minutes after consuming the meal. At the same times, capillary blood glucose will also be measured, the glucose sensor readings from the pump will be recorded as well. The meal test will then begin, using different meal coverage approaches to be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
August 21, 2026
CompletedFirst Posted
Study publicly available on registry
August 25, 2026
CompletedAugust 25, 2026
August 1, 2026
6 months
August 21, 2026
August 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum Postprandial Glucose Incremental Area Under the Curve (iAUC)(mg·h/dL)
0-4 hours after consumption of the standardized meal
Study Arms (3)
open-loop dual-wave bolus, insulin increased by 50% for fat/protein, 50% upfront and 50% over 4h
OTHERThe carbohydrate content of the meal (64 g) will be declared, and the meal insulin dose will be increased by 30% for fat and 20% for protein, a total increase of 50%. The dual-wave bolus pattern of insulin delivery will be used: 50% of the recommended dose will be given 10 minutes before the meal, and the remaining 50% will be delivered as an extended bolus over the next 4 hours
closed-loop standard carbohydrate-based bolus
OTHERA single insulin bolus in closed-loop conditions, only the carbohydrate grams of the meal will be declared (as fat and protein are not recommended to be included in the bolus calculation with the 780G pump). The pump will deliver a single bolus of insulin 10 minutes before the meal.
closed-loop standard bolus plus 50% supplementary bolus 1 h after meal initiation
OTHERParticipants assigned to this sequence will receive the same predetermined amount of pizza in closed-loop conditions. Ten minutes before the meal, 64 g of carbohydrates will be declared, and 1 hour after the meal has started, the insulin dose will be increased by 30% for fat and 20% for protein, a total of 50%, calculated based on 50% of the carbohydrate grams declared before the meal
Interventions
Participants receive the standard meal insulin bolus for a standardized pizza meal while using the MiniMed 780G advanced hybrid closed-loop system. The meal bolus is calculated according to each participant's individual insulin-to-carbohydrate ratio.The pump will deliver a single bolus of insulin 10 minutes before the meal.
Participants receive the standard meal insulin bolus for a standardized pizza meal while using the MiniMed 780G advanced hybrid closed-loop system, followed by a supplementary insulin bolus according to the predefined study protocol.
The carbohydrate content of the meal will be declared, and the meal insulin dose will be increased by 30% for fat and 20% for protein, a total increase of 50%. The dual-wave bolus pattern of insulin delivery will be used: 50% of the recommended dose will be given 10 minutes before the meal, and the remaining 50% will be delivered as an extended bolus over the next 4 hours. The meal bolus is calculated according to each participant's individual insulin-to-carbohydrate ratio.
Eligibility Criteria
You may qualify if:
- Diagnosis of Type 1 Diabetes (T1D) at least 12 months prior to study participation
- Use of continuous subcutaneous insulin infusion (CSII) pump for at least 6 months prior to enrollment ("trained" patients)
- Adequate glycemic control (recent HbA1c value ≤ 8%)
You may not qualify if:
- Known microvascular and macrovascular complications of diabetes
- History of gastroparesis or malabsorption
- History of stomach or intestinal surgery
- Use of medications that affect gastrointestinal motility (e.g., prokinetics, antiemetics, GLP-1 agonists, etc.)
- Known deficiency of fat-soluble vitamins (A, D, E, K)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diabetes Laboratory, 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Laiko General Hospital, Athens, Greece
Athens, Athens, 11527, Greece
Related Publications (5)
Bell KJ, Fio CZ, Twigg S, Duke SA, Fulcher G, Alexander K, McGill M, Wong J, Brand-Miller J, Steil GM. Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial. Diabetes Care. 2020 Jan;43(1):59-66. doi: 10.2337/dc19-0687. Epub 2019 Aug 27.
PMID: 31455688BACKGROUNDBell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015 Jun;38(6):1008-15. doi: 10.2337/dc15-0100.
PMID: 25998293BACKGROUNDSmith TA, Marlow AA, King BR, Smart CE. Insulin strategies for dietary fat and protein in type 1 diabetes: A systematic review. Diabet Med. 2021 Nov;38(11):e14641. doi: 10.1111/dme.14641. Epub 2021 Jul 18.
PMID: 34251692BACKGROUNDHeinemann L. Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements? J Diabetes Sci Technol. 2009 Nov 1;3(6):1490-500. doi: 10.1177/193229680900300631.
PMID: 20144405BACKGROUNDCavagnuolo L, Bozzetto L, Franco L, Costabile G, Riccardi G, Rivellese AA, Annuzzi G. Pizza Leavening Technique Influences Postprandial Glucose Response: A Randomized Controlled Trial in Patients With Type 1 Diabetes. Diabetes Care. 2019 Oct;42(10):e157-e158. doi: 10.2337/dc19-0778. Epub 2019 Aug 15. No abstract available.
PMID: 31416896BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Konstantinos Makrilakis, MD, PhD
National and Kapodistrian University of Athens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
August 21, 2026
First Posted
August 25, 2026
Study Start
June 30, 2025
Primary Completion
December 15, 2025
Study Completion
December 15, 2025
Last Updated
August 25, 2026
Record last verified: 2026-08